Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 23;16(5):e60961.
doi: 10.7759/cureus.60961. eCollection 2024 May.

Dengue Fever Accompanied by Neurological Manifestations: Challenges and Treatment

Affiliations
Review

Dengue Fever Accompanied by Neurological Manifestations: Challenges and Treatment

Jay P Patel et al. Cureus. .

Abstract

Dengue, commonly referred to as 'breakbone fever,' is a mosquito-borne arboviral infection transmitted by Aedes aegypti, featuring an average incubation period of approximately seven days. Key cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor (TNF)-α, and interleukin (IL)-10 are pivotal in the pathogenesis of dengue. Travelers are particularly susceptible to contracting dengue fever, with disease severity often associated with CD8+ T cell response. Without proper hospitalization during severe cases like dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS), mortality rates can escalate to 50%. Dengue fever can lead to various complications, including neurological manifestations such as encephalopathy, encephalitis, cerebral venous thrombosis, myelitis, posterior reversible encephalopathy syndrome, strokes (both ischemic and hemorrhagic), immune-mediated neurological syndromes (such as mononeuropathy, acute transverse myelitis, Guillain-Barre syndrome, and acute disseminated encephalomyelitis), and neuromuscular complications. Treatment protocols typically involve assessing disease activity using composite indices, pursuing treatment objectives, and administering intravenous fluids according to symptomatology. Given the absence of specific antiviral treatment for dengue, supportive care, particularly hydration, remains paramount during the early stages. It is crucial to recognize that dengue viruses may contribute to the development of neurological disorders, particularly in regions where dengue is endemic. Furthermore, there is a necessity for well-defined criteria for specific neurological complications. Primary prevention strategies primarily revolve around vector control measures, which play a critical role in curtailing the spread of dengue.

Keywords: dengue complication; dengue encephalitis; dengue fever (df); dengue fever/complications; dengue viruses; dengue with warning signs; dengue-related hospitalization; evolution of dengue; expanded dengue synrome; neurological manifestations of dengue.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. A summarized flowchart of the dengue infection classification
Image credit: author Jay P. Patel
Figure 2
Figure 2. A summarized flowchart of neurological complications in dengue
Image credit: author Jay P. Patel

References

    1. Dengue fever. Kularatne SA. BMJ. 2015;351:0. - PubMed
    1. Dengue fever. Waterman SH, Gubler DJ. Clin Dermatol. 1989;7:117–122. - PubMed
    1. Concurrent dengue infections: epidemiology & clinical implications. N Sirisena PD, Mahilkar S, Sharma C, Jain J, Sunil S. Indian J Med Res. 2021;154:669–679. - PMC - PubMed
    1. Dengue infections in travellers. Wilder-Smith A. Paediatr Int Child Health. 2012;32:28–32. - PMC - PubMed
    1. Dengue fever and international travel. Ratnam I, Leder K, Black J, Torresi J. J Travel Med. 2013;20:384–393. - PubMed

LinkOut - more resources